In Q1 2025, 24% of patients with both diabetes/obesity and OSA initiated a GLP-1 therapy within six months of diagnosis, compared to 18% of patients with diabetes/obesity alone
Avoid the inner arm and anything close to the shoulder joint
Thus, weight loss maintenance with GLP-1RA may act to prevent pre-diabetes in obesity
Storage: Prior to reconstitution, store vials in a controlled environment at -20C for long-term stability
Additionally, GLP-1 injections enhance insulin secretion in response to food, allowing the body to process glucose more efficiently, while also reducing glucagon release, a hormone that can raise blood sugar
Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction by Activating -Arrestin-2, Protein Phosphatase 2A, and Glycogen Synthase Kinase-3 and Inhibiting -Catenin